A Phase 1, Single-Blind, Randomized, Placebo-Controlled, Single-Dose or Open-Label Multiple-Dose Study of KHK4083 in Healthy Adults and Subjects With Ulcerative Colitis
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2017
At a glance
- Drugs KHK 4083 (Primary) ; KHK 4083 (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors Kyowa Hakko Kirin
- 15 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Sep 2017 Planned End Date changed from 1 Jun 2018 to 1 Jan 2018.
- 14 Sep 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jan 2018.